195 related articles for article (PubMed ID: 18779312)
21. Nicotine 5'-oxidation and methyl oxidation by P450 2A enzymes.
Murphy SE; Raulinaitis V; Brown KM
Drug Metab Dispos; 2005 Aug; 33(8):1166-73. PubMed ID: 15860657
[TBL] [Abstract][Full Text] [Related]
22. Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants.
Shimada T; Murayama N; Kakimoto K; Takenaka S; Lim YR; Yeom S; Kim D; Yamazaki H; Guengerich FP; Komori M
Xenobiotica; 2018 Jun; 48(6):565-575. PubMed ID: 28648140
[TBL] [Abstract][Full Text] [Related]
23. Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants.
Yun CH; Miller GP; Guengerich FP
Biochemistry; 2000 Sep; 39(37):11319-29. PubMed ID: 10985777
[TBL] [Abstract][Full Text] [Related]
24. Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.
Lewis DF; Lake BG
Xenobiotica; 2002 Jul; 32(7):547-61. PubMed ID: 12162851
[TBL] [Abstract][Full Text] [Related]
25. The Influence of Tobacco Smoke/Nicotine on CYP2A Expression in Human and African Green Monkey Lungs.
Gao Y; Miksys S; Palmour RM; Tyndale RF
Mol Pharmacol; 2020 Dec; 98(6):658-668. PubMed ID: 33055223
[TBL] [Abstract][Full Text] [Related]
26. Chimeric cDNA expression and site directed mutagenesis studies of cytochrome P450s CYP2A1 and CYP2A2.
Hanioka N; Gonzalez FJ; Lindberg NA; Liu G; Korzekwa KR
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):1037-43. PubMed ID: 22217848
[TBL] [Abstract][Full Text] [Related]
27. Increased Phenacetin Oxidation upon the L382V Substitution in Cytochrome P450 1A2 is Associated with Altered Substrate Binding Orientation.
Huang Q; Szklarz GD
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29799514
[TBL] [Abstract][Full Text] [Related]
28. Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35).
Han S; Choi S; Chun YJ; Yun CH; Lee CH; Shin HJ; Na HS; Chung MW; Kim D
Biol Pharm Bull; 2012; 35(3):394-9. PubMed ID: 22382327
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzyme.
Hernandez CE; Kumar S; Liu H; Halpert JR
Arch Biochem Biophys; 2006 Nov; 455(1):61-7. PubMed ID: 17027909
[TBL] [Abstract][Full Text] [Related]
30. Structure, function, regulation and polymorphism of human cytochrome P450 2A6.
Di YM; Chow VD; Yang LP; Zhou SF
Curr Drug Metab; 2009 Sep; 10(7):754-80. PubMed ID: 19702528
[TBL] [Abstract][Full Text] [Related]
31. Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes.
Nakajima M; Kobayashi K; Oshima K; Shimada N; Tokudome S; Chiba K; Yokoi T
Xenobiotica; 1999 Sep; 29(9):885-98. PubMed ID: 10548449
[TBL] [Abstract][Full Text] [Related]
32. CYP2A6: genetics, structure, regulation, and function.
Raunio H; Rahnasto-Rilla M
Drug Metabol Drug Interact; 2012 May; 27(2):73-88. PubMed ID: 22706231
[TBL] [Abstract][Full Text] [Related]
33. Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.
Chiang HC; Wang CY; Lee HL; Tsou TC
Toxicol Appl Pharmacol; 2011 Jun; 253(2):145-52. PubMed ID: 21473878
[TBL] [Abstract][Full Text] [Related]
34. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity.
Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO
Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807
[TBL] [Abstract][Full Text] [Related]
35. Substrate Selectivities and Catalytic Activities of Marmoset Liver Cytochrome P450 2A6 Differed from Those of Human P450 2A6.
Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2015 Jul; 43(7):969-76. PubMed ID: 25858611
[TBL] [Abstract][Full Text] [Related]
36. CYP2A6 AND CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions.
Yamanaka H; Nakajima M; Fukami T; Sakai H; Nakamura A; Katoh M; Takamiya M; Aoki Y; Yokoi T
Drug Metab Dispos; 2005 Dec; 33(12):1811-8. PubMed ID: 16135656
[TBL] [Abstract][Full Text] [Related]
37. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Su T; Bao Z; Zhang QY; Smith TJ; Hong JY; Ding X
Cancer Res; 2000 Sep; 60(18):5074-9. PubMed ID: 11016631
[TBL] [Abstract][Full Text] [Related]
38. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
Zhang W; Kilicarslan T; Tyndale RF; Sellers EM
Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760
[TBL] [Abstract][Full Text] [Related]
40. Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.
Huang Q; Deshmukh RS; Ericksen SS; Tu Y; Szklarz GD
Drug Metab Dispos; 2012 Dec; 40(12):2324-31. PubMed ID: 22949628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
